Sage Therapeutics, Inc. Stock Split Ratio
Sage Therapeutics, Inc. reported Stock Split Ratio of 31.75% for the 0-month period ending 2014-07-02, per its 10-K filed 2017-02-24.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2017-02-24
- 2014-07-02: Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month 31.75%; Stockholders' Equity Note, Stock Split, Conversion Ratio 31.75%; Stockholders' Equity Note, Stock Split, Conversion Ratio as first filed 31.74%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio as first filed |
|---|---|---|---|
| 2014-07-02 | 31.75% 10-K · filed 2017-02-24 | 31.75% 10-K · filed 2016-02-29 | 31.74% 10-Q · filed 2014-11-13 |